论文部分内容阅读
本文报道用汕头经济特区滨-华明厂生产的阿霉素,组成联合方案治疗恶性肿瘤27例的近期观察结果。临床资料一、一般资料本组27例病人,除7例依靠临床症状和体征,血清学及其它辅助检查(CT、X线、B超等)诊断外,余20例为病理或细胞学确诊。27例中,男21例,女6例;年龄最小6岁,最大75岁;16例为初治病例;1例放疗后复发;4例化疗加局部放疗;3例术后辅助化疗;3例术后、放疗后局部复发、远处转移者;病种以淋巴瘤、肺癌居多(见表);几乎为晚期病例。
This article reports on the recent observations of 27 cases of malignant tumors that were made with adriamycin produced in the Shantou-Shantou Special Economic Zone. Clinical data I. General information In this group of 27 patients, except for 7 cases that depended on clinical symptoms and signs, serology, and other auxiliary examinations (CT, X-ray, B ultrasound, etc.), the remaining 20 cases were confirmed by pathology or cytology. In 27 cases, there were 21 males and 6 females; the youngest was 6 years old and the oldest was 75 years old; 16 cases were untreated cases; 1 case had recurrence after radiotherapy; 4 cases received chemotherapy and local radiotherapy; 3 cases received postoperative adjuvant chemotherapy; 3 cases After surgery, local recurrence after radiotherapy, distant metastasis; the disease species are lymphoma, lung cancer (see table); almost advanced cases.